Clifford Goodman
Senior Vice President
Clifford Goodman, PhD, has more than 30 years of experience in health technology assessment, comparative effectiveness research, clinical practice guidelines, health economics and studies pertaining to health care innovation, regulation and payment. He directs studies and projects for government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry and patient advocacy groups. His work has involved such areas as chronic disease, infectious disease, cancer, rare diseases, diagnostic testing, gene therapy, pharmacogenomics, personalized medicine, biosimilars, value frameworks, value-based contracting, social determinants of health, and applications of real-world evidence. He is an internationally recognized health policy issues moderator and facilitator of expert panels, advisory boards, workshops and focus groups.
Dr. Goodman was Chair of the Medicare Evidence Development & Coverage Advisory Committee (2009-12) for the Centers for Medicare and Medicaid Services. He was president of the professional society, Health Technology Assessment International (HTAi) (2011-13) and is a Fellow of the American Institute for Medical and Biological Engineering. In 2022, he received the David Banta Distinguished Career Award in Health Technology Assessment from HTAi.
He earned a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University.